Household & Personal Products

How Kenvue’s Tylenol‑autism lawsuit threatens its stock and strategy – read the latest risk analysis.

Care Brands Inc. secures worldwide rights to produce and distribute Itonis’s drug Emesyl, expanding its portfolio into pharma and boosting future revenue potential.

Bonk Inc. stock falls from $42 to $2.75, negative P/E and low P/B reveal deep losses and market uncertainty in the consumer staples sector.

Clorox’s declining stock, high dividend yield fueled by a steep price drop, and stagnant growth signal investors must reassess exposure before buying.

Upexi’s Nasdaq Closing Bell ceremony highlights its data‑driven eCommerce strategy amid volatile stock swings, offering insight into a $110M consumer‑staples play.

Discover how Henkel AG & Co. KGaA leads the household products sector with a 28 billion‑EUR market cap, sustainable innovations, and a strong 13.07 P/E ratio, driving steady growth.

Kimberly‑Clark’s disciplined brand‑investment and steady dividend growth make it a top‑choice consumer‑staple stock poised for upside.

Bioxyne Limited’s latest filings show a dual strategy to raise cash and boost market visibility amid low share prices, offering investors a detailed look at the company’s capital‑raising tactics and regulatory transparency.

Henkel’s share‑buyback boosts EPS and signals confidence in its €28.4 billion market cap, positioning the consumer‑staples firm for stronger shareholder returns amid a rising DAX.

JPMorgan cuts e.l.f. Beauty’s target to $103, citing high valuation and margin risks—will the brand’s growth win back investor confidence?